Malaria Diagnostics Global Market Overview, 2021-2023 & 2024-2030 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Malaria Diagnostics - A Global Market Overview" report has been added to ResearchAndMarkets.com's offering.

The global Malaria Diagnostics market is estimated at US$808.04 million in 2024 and is expected to record a CAGR of 5.3% during the 2024-2030 analysis period and stand at a projected US$1.1 billion by 2030.

The global Malaria Diagnostics market is driven by several key growth trends which include the rising incidence of malaria in various regions, particularly in sub-Saharan Africa and parts of Asia and increased awareness of malaria's impact on public health has led to greater investment in diagnostic technologies and research.

Additionally, the push for rapid and accurate detection methods, such as Rapid Diagnostic Tests (RDTs) and molecular diagnostics, has gained momentum due to their crucial role in effective disease management. Support from global health organizations and government initiatives aimed at eradicating malaria further fuels market growth, along with the integration of diagnostics into broader health systems to enhance surveillance and response efforts.

Malaria Diagnostics Regional Market Analysis

The Middle East & Africa region holds the dominant position in the Malaria Diagnostics market, accounting for 86.3% in 2024, due to the high burden of malaria cases and the significant prevalence of the disease in the region. Meanwhile, the Asia-Pacific region is projected to be the fastest-growing market, with a CAGR of 6.1% during the forecast period 2024-2030.

This growth is driven by factors such as the high prevalence of malaria in countries like India, Myanmar, and Indonesia and investment by governments and international organizations in public health initiatives. Additionally, advancements in technology and increased awareness of malaria control have accelerated the adoption of diagnostic tools in the region.

Malaria Diagnostics Market Analysis by Technology

Rapid Diagnostic Tests is a leading Technology in the Malaria Diagnostics market, with an estimated share of 61.8% in 2024, owing to their ease of use, portability, cost-effectiveness, and ability to provide quick and accurate results. In regions with limited healthcare infrastructure, RDTs offer a practical alternative to more complex diagnostic which require skilled technicians and laboratory facilities and can be performed by minimally trained healthcare workers and are effective in detecting malaria within 15-30 minutes, allowing for timely diagnosis and treatment.

Conversely, Molecular Diagnostics tests is expected to record the fastest CAGR of 5.6% during the 2024-2030 forecast period due to its due to its superior accuracy and sensitivity compared to traditional diagnostic methods. Molecular techniques, such as polymerase chain reaction (PCR), can detect low levels of malaria parasites, enabling early and precise identification of infections, even in asymptomatic patients.

Malaria Diagnostics Market Analysis by End-Use Sector

The Clinics segment led the market with a 51.4% share in 2024, as clinics serve as the primary point of care for patients in both urban and rural areas, especially in malaria-endemic regions. Clinics often have the necessary infrastructure and healthcare professionals to perform diagnostic tests, such as rapid diagnostic tests (RDTs) and microscopy. Additionally, clinics are well-integrated into local healthcare systems, allowing for prompt treatment following diagnosis, which is crucial for effective malaria management. On the other hand, Diagnostic Centers segment is expected to register the fastest CAGR of 5.7% during the forecast period 2024-2030, driven by the increasing accessibility, better infrastructure for accurate testing, and rising demand for early diagnosis in both urban and rural areas.

Malaria Diagnostics Market Report Scope

This global report on Malaria Diagnostics analyzes the market based on type and end-use sector. In addition to providing profiles of major companies operating in this space, the latest corporate and industrial developments have been covered to offer a clear panorama of how and where the market is progressing.

Key Attributes:

Report Attribute	Details
No. of Pages	295
Forecast Period	2024 - 2030
Estimated Market Value (USD) in 2024	$808 million
Forecasted Market Value (USD) by 2030	$1100 million
Compound Annual Growth Rate	5.3%
Regions Covered	Global

Key Metrics

• Historical Period: 2021-2023
• Base Year: 2023
• Forecast Period: 2024-2030
• Units: Value market in US$

Key Topics Covered:

Market Perspective

• Product Outline
• Malaria Diagnostics Defined
• Malaria Diagnostics Technology
• Microscopy
• Rapid Diagnostic Tests
• Molecular Diagnostic Tests
• Malaria Diagnostics End-Use Sectors
• Hospitals
• Clinics
• Diagnostics Centers

Key Global Players

• Abbott Laboratories
• Access Bio., Inc.
• Beckman Coulter, Inc.
• bioMerieux
• Bio-Rad Laboratories, Inc.
• Leica Microsystems GmbH
• Meridian Bioscience, Inc.
• Nikon Corporation
• Olympus Corporation
• Premier Medical Corporation Pvt. Ltd.
• Siemens Healthineers
• Sysmex Partec GmbH

Global Market Overview

• Global Malaria Diagnostics Market Overview by Technology
• Malaria Diagnostics Technology Market Overview by Global Region
• Microscopy
• Rapid Diagnostic Tests
• Molecular Diagnostic Tests
• Global Malaria Diagnostics Market Overview by End-Use Sector
• Malaria Diagnostics End-Use Sector Market Overview by Global Region
• Hospitals
• Clinics
• Diagnostics Centers

For more information about this report visit https://www.researchandmarkets.com/r/rswv

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.